申请人:SHILPA MEDICARE LIMITED
公开号:US20150344409A1
公开(公告)日:2015-12-03
The present invention provides process for preparation of Fingolimod hydrochloride (I).
Fingolimod hydrochloride (I) as Form-β obtained by the process of present invention may be useful as active pharmaceutical ingredient in pharmaceutical compositions for the treatment of autoimmune related disorder including multiple sclerosis.
本发明提供了一种制备盐酸非吡格雷(I)的方法。通过本发明的方法获得的Form-β型盐酸非吡格雷(I)可用作制药组合物中的活性药物成分,用于治疗自身免疫相关疾病,包括多发性硬化症。